Gamow Labs Turns a Missed NICU Diagnosis Into a Genomics Startup
The Boulder company is building an AI interpretation layer for whole genomes, after its founder says standard testing missed his son's fatal disorder.
By Ryan Merket · Published
Primary source: ddmckinnon.com
Why it matters
Gamow Labs is aimed at the hard part of clinical genomics: not generating a genome, but interpreting it fast enough for sick infants. If coverage expands, interpretation capacity becomes the choke point.
Gamow Labs was introduced this week by a founder who says the company began with the death of his first son and a question the clinical genomics system could not answer fast enough: why had whole-genome sequencing missed the mutation that mattered?…